nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Malaise—Floxuridine—stomach cancer	0.00838	0.0144	CcSEcCtD
Betahistine—Vasodilation—Irinotecan—stomach cancer	0.00824	0.0142	CcSEcCtD
Betahistine—Vasodilation procedure—Irinotecan—stomach cancer	0.00824	0.0142	CcSEcCtD
Betahistine—Discomfort—Floxuridine—stomach cancer	0.00781	0.0134	CcSEcCtD
Betahistine—Confusional state—Floxuridine—stomach cancer	0.00764	0.0131	CcSEcCtD
Betahistine—Anaphylactic shock—Floxuridine—stomach cancer	0.00758	0.013	CcSEcCtD
Betahistine—Nervous system disorder—Floxuridine—stomach cancer	0.00743	0.0128	CcSEcCtD
Betahistine—Dermatitis atopic—Docetaxel—stomach cancer	0.00676	0.0116	CcSEcCtD
Betahistine—Ill-defined disorder—Mitomycin—stomach cancer	0.00676	0.0116	CcSEcCtD
Betahistine—Malaise—Mitomycin—stomach cancer	0.00657	0.0113	CcSEcCtD
Betahistine—Feeling abnormal—Floxuridine—stomach cancer	0.00625	0.0107	CcSEcCtD
Betahistine—Discomfort—Mitomycin—stomach cancer	0.00613	0.0105	CcSEcCtD
Betahistine—Confusional state—Mitomycin—stomach cancer	0.006	0.0103	CcSEcCtD
Betahistine—Hypersensitivity—Floxuridine—stomach cancer	0.00558	0.0096	CcSEcCtD
Betahistine—Asthenia—Floxuridine—stomach cancer	0.00544	0.00935	CcSEcCtD
Betahistine—Ventricular extrasystoles—Capecitabine—stomach cancer	0.00537	0.00922	CcSEcCtD
Betahistine—Dyspnoea—Mitomycin—stomach cancer	0.0053	0.00911	CcSEcCtD
Betahistine—Somnolence—Mitomycin—stomach cancer	0.00529	0.00909	CcSEcCtD
Betahistine—Diarrhoea—Floxuridine—stomach cancer	0.00519	0.00891	CcSEcCtD
Betahistine—Fatigue—Mitomycin—stomach cancer	0.00513	0.00881	CcSEcCtD
Betahistine—Feeling abnormal—Mitomycin—stomach cancer	0.0049	0.00842	CcSEcCtD
Betahistine—Vomiting—Floxuridine—stomach cancer	0.00482	0.00828	CcSEcCtD
Betahistine—Orthostatic hypotension—Irinotecan—stomach cancer	0.0048	0.00825	CcSEcCtD
Betahistine—Rash—Floxuridine—stomach cancer	0.00478	0.00821	CcSEcCtD
Betahistine—Dermatitis—Floxuridine—stomach cancer	0.00478	0.00821	CcSEcCtD
Betahistine—Headache—Floxuridine—stomach cancer	0.00475	0.00816	CcSEcCtD
Betahistine—Abdominal distension—Irinotecan—stomach cancer	0.00457	0.00786	CcSEcCtD
Betahistine—Dermatitis atopic—Epirubicin—stomach cancer	0.00456	0.00784	CcSEcCtD
Betahistine—Nausea—Floxuridine—stomach cancer	0.0045	0.00774	CcSEcCtD
Betahistine—Asthenia—Mitomycin—stomach cancer	0.00427	0.00734	CcSEcCtD
Betahistine—Dermatitis atopic—Doxorubicin—stomach cancer	0.00422	0.00725	CcSEcCtD
Betahistine—Diarrhoea—Mitomycin—stomach cancer	0.00407	0.007	CcSEcCtD
Betahistine—Dizziness—Mitomycin—stomach cancer	0.00393	0.00676	CcSEcCtD
Betahistine—Vasodilation procedure—Epirubicin—stomach cancer	0.00384	0.0066	CcSEcCtD
Betahistine—Vasodilation—Epirubicin—stomach cancer	0.00384	0.0066	CcSEcCtD
Betahistine—Vomiting—Mitomycin—stomach cancer	0.00378	0.0065	CcSEcCtD
Betahistine—Rash—Mitomycin—stomach cancer	0.00375	0.00645	CcSEcCtD
Betahistine—Dermatitis—Mitomycin—stomach cancer	0.00375	0.00644	CcSEcCtD
Betahistine—Ventricular extrasystoles—Epirubicin—stomach cancer	0.00374	0.00642	CcSEcCtD
Betahistine—Headache—Mitomycin—stomach cancer	0.00373	0.0064	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—stomach cancer	0.00356	0.00611	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—stomach cancer	0.00356	0.00611	CcSEcCtD
Betahistine—Nausea—Mitomycin—stomach cancer	0.00353	0.00607	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—stomach cancer	0.00346	0.00594	CcSEcCtD
Betahistine—Orthostatic hypotension—Docetaxel—stomach cancer	0.00332	0.0057	CcSEcCtD
Betahistine—Abdominal pain upper—Docetaxel—stomach cancer	0.00332	0.0057	CcSEcCtD
Betahistine—Immune system disorder—Irinotecan—stomach cancer	0.00328	0.00564	CcSEcCtD
Betahistine—Orthostatic hypotension—Capecitabine—stomach cancer	0.00321	0.00552	CcSEcCtD
Betahistine—Abdominal pain upper—Capecitabine—stomach cancer	0.00321	0.00552	CcSEcCtD
Betahistine—Flatulence—Irinotecan—stomach cancer	0.00312	0.00536	CcSEcCtD
Betahistine—Bronchospasm—Docetaxel—stomach cancer	0.00309	0.00531	CcSEcCtD
Betahistine—Abdominal distension—Capecitabine—stomach cancer	0.00306	0.00526	CcSEcCtD
Betahistine—Asthma—Capecitabine—stomach cancer	0.00304	0.00523	CcSEcCtD
Betahistine—Bronchospasm—Capecitabine—stomach cancer	0.00299	0.00514	CcSEcCtD
Betahistine—Ill-defined disorder—Irinotecan—stomach cancer	0.00294	0.00505	CcSEcCtD
Betahistine—Malaise—Irinotecan—stomach cancer	0.00285	0.00491	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.00278	0.00477	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.00269	0.00462	CcSEcCtD
Betahistine—Discomfort—Irinotecan—stomach cancer	0.00266	0.00458	CcSEcCtD
Betahistine—Convulsion—Fluorouracil—stomach cancer	0.00263	0.00451	CcSEcCtD
Betahistine—Confusional state—Irinotecan—stomach cancer	0.0026	0.00448	CcSEcCtD
Betahistine—Anaphylactic shock—Irinotecan—stomach cancer	0.00258	0.00444	CcSEcCtD
Betahistine—Discomfort—Fluorouracil—stomach cancer	0.00255	0.00438	CcSEcCtD
Betahistine—Nervous system disorder—Irinotecan—stomach cancer	0.00253	0.00435	CcSEcCtD
Betahistine—Confusional state—Fluorouracil—stomach cancer	0.00249	0.00429	CcSEcCtD
Betahistine—Anaphylactic shock—Fluorouracil—stomach cancer	0.00247	0.00425	CcSEcCtD
Betahistine—Nervous system disorder—Fluorouracil—stomach cancer	0.00243	0.00417	CcSEcCtD
Betahistine—Tachycardia—Fluorouracil—stomach cancer	0.00241	0.00415	CcSEcCtD
Betahistine—Erythema multiforme—Docetaxel—stomach cancer	0.00238	0.00408	CcSEcCtD
Betahistine—Dyspnoea—Irinotecan—stomach cancer	0.0023	0.00396	CcSEcCtD
Betahistine—Erythema multiforme—Capecitabine—stomach cancer	0.0023	0.00395	CcSEcCtD
Betahistine—Somnolence—Irinotecan—stomach cancer	0.0023	0.00395	CcSEcCtD
Betahistine—Dyspepsia—Irinotecan—stomach cancer	0.00227	0.00391	CcSEcCtD
Betahistine—Immune system disorder—Docetaxel—stomach cancer	0.00227	0.0039	CcSEcCtD
Betahistine—Asthma—Methotrexate—stomach cancer	0.00226	0.00389	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—stomach cancer	0.00224	0.00385	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—stomach cancer	0.00224	0.00385	CcSEcCtD
Betahistine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00223	0.00383	CcSEcCtD
Betahistine—Fatigue—Irinotecan—stomach cancer	0.00223	0.00383	CcSEcCtD
Betahistine—Dyspnoea—Fluorouracil—stomach cancer	0.00221	0.00379	CcSEcCtD
Betahistine—Somnolence—Fluorouracil—stomach cancer	0.0022	0.00378	CcSEcCtD
Betahistine—Immune system disorder—Capecitabine—stomach cancer	0.0022	0.00378	CcSEcCtD
Betahistine—Dyspepsia—Fluorouracil—stomach cancer	0.00218	0.00374	CcSEcCtD
Betahistine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00214	0.00367	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—stomach cancer	0.00213	0.00366	CcSEcCtD
Betahistine—Feeling abnormal—Irinotecan—stomach cancer	0.00213	0.00366	CcSEcCtD
Betahistine—Asthma—Epirubicin—stomach cancer	0.00212	0.00364	CcSEcCtD
Betahistine—Flatulence—Capecitabine—stomach cancer	0.00209	0.00359	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—stomach cancer	0.00207	0.00356	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00207	0.00356	CcSEcCtD
Betahistine—Feeling abnormal—Fluorouracil—stomach cancer	0.00204	0.0035	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.002	0.00344	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—stomach cancer	0.00197	0.00339	CcSEcCtD
Betahistine—Ill-defined disorder—Capecitabine—stomach cancer	0.00197	0.00338	CcSEcCtD
Betahistine—Urticaria—Fluorouracil—stomach cancer	0.00197	0.00338	CcSEcCtD
Betahistine—Asthma—Doxorubicin—stomach cancer	0.00196	0.00337	CcSEcCtD
Betahistine—Malaise—Capecitabine—stomach cancer	0.00191	0.00328	CcSEcCtD
Betahistine—Hypersensitivity—Irinotecan—stomach cancer	0.0019	0.00327	CcSEcCtD
Betahistine—Convulsion—Docetaxel—stomach cancer	0.0019	0.00326	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00187	0.00322	CcSEcCtD
Betahistine—Asthenia—Irinotecan—stomach cancer	0.00185	0.00319	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00185	0.00318	CcSEcCtD
Betahistine—Hypersensitivity—Fluorouracil—stomach cancer	0.00182	0.00313	CcSEcCtD
Betahistine—Confusional state—Docetaxel—stomach cancer	0.0018	0.00309	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00179	0.00308	CcSEcCtD
Betahistine—Anaphylactic shock—Docetaxel—stomach cancer	0.00179	0.00307	CcSEcCtD
Betahistine—Discomfort—Capecitabine—stomach cancer	0.00178	0.00306	CcSEcCtD
Betahistine—Diarrhoea—Irinotecan—stomach cancer	0.00177	0.00304	CcSEcCtD
Betahistine—Nervous system disorder—Docetaxel—stomach cancer	0.00175	0.00301	CcSEcCtD
Betahistine—Pruritus—Fluorouracil—stomach cancer	0.00175	0.00301	CcSEcCtD
Betahistine—Confusional state—Capecitabine—stomach cancer	0.00174	0.003	CcSEcCtD
Betahistine—Tachycardia—Docetaxel—stomach cancer	0.00174	0.003	CcSEcCtD
Betahistine—Skin disorder—Docetaxel—stomach cancer	0.00173	0.00298	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00173	0.00298	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—stomach cancer	0.00171	0.00294	CcSEcCtD
Betahistine—Dizziness—Irinotecan—stomach cancer	0.00171	0.00294	CcSEcCtD
Betahistine—Nervous system disorder—Capecitabine—stomach cancer	0.0017	0.00291	CcSEcCtD
Betahistine—Diarrhoea—Fluorouracil—stomach cancer	0.00169	0.00291	CcSEcCtD
Betahistine—Tachycardia—Capecitabine—stomach cancer	0.00169	0.0029	CcSEcCtD
Betahistine—Skin disorder—Capecitabine—stomach cancer	0.00168	0.00289	CcSEcCtD
Betahistine—Vomiting—Irinotecan—stomach cancer	0.00164	0.00282	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—stomach cancer	0.00164	0.00281	CcSEcCtD
Betahistine—Dizziness—Fluorouracil—stomach cancer	0.00164	0.00281	CcSEcCtD
Betahistine—Rash—Irinotecan—stomach cancer	0.00163	0.0028	CcSEcCtD
Betahistine—Dermatitis—Irinotecan—stomach cancer	0.00163	0.0028	CcSEcCtD
Betahistine—Headache—Irinotecan—stomach cancer	0.00162	0.00278	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—stomach cancer	0.0016	0.00276	CcSEcCtD
Betahistine—Dyspnoea—Docetaxel—stomach cancer	0.00159	0.00274	CcSEcCtD
Betahistine—Somnolence—Docetaxel—stomach cancer	0.00159	0.00273	CcSEcCtD
Betahistine—Vomiting—Fluorouracil—stomach cancer	0.00157	0.0027	CcSEcCtD
Betahistine—Dyspepsia—Docetaxel—stomach cancer	0.00157	0.0027	CcSEcCtD
Betahistine—Rash—Fluorouracil—stomach cancer	0.00156	0.00268	CcSEcCtD
Betahistine—Dermatitis—Fluorouracil—stomach cancer	0.00156	0.00268	CcSEcCtD
Betahistine—Headache—Fluorouracil—stomach cancer	0.00155	0.00266	CcSEcCtD
Betahistine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00154	0.00265	CcSEcCtD
Betahistine—Dyspnoea—Capecitabine—stomach cancer	0.00154	0.00265	CcSEcCtD
Betahistine—Fatigue—Docetaxel—stomach cancer	0.00154	0.00265	CcSEcCtD
Betahistine—Nausea—Irinotecan—stomach cancer	0.00153	0.00264	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.00153	0.00367	CbGpPWpGaD
Betahistine—Immune system disorder—Epirubicin—stomach cancer	0.00153	0.00263	CcSEcCtD
Betahistine—Dyspepsia—Capecitabine—stomach cancer	0.00152	0.00262	CcSEcCtD
Betahistine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00149	0.00257	CcSEcCtD
Betahistine—Fatigue—Capecitabine—stomach cancer	0.00149	0.00256	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—ANXA1—stomach cancer	0.00149	0.00356	CbGpPWpGaD
Betahistine—Erythema multiforme—Doxorubicin—stomach cancer	0.00148	0.00255	CcSEcCtD
Betahistine—Feeling abnormal—Docetaxel—stomach cancer	0.00147	0.00253	CcSEcCtD
Betahistine—Nausea—Fluorouracil—stomach cancer	0.00147	0.00253	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—stomach cancer	0.00146	0.00251	CcSEcCtD
Betahistine—Flatulence—Epirubicin—stomach cancer	0.00145	0.0025	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—ADRB1—stomach cancer	0.00144	0.00344	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—stomach cancer	0.00144	0.00344	CbGpPWpGaD
Betahistine—Feeling abnormal—Capecitabine—stomach cancer	0.00142	0.00245	CcSEcCtD
Betahistine—Malaise—Methotrexate—stomach cancer	0.00142	0.00244	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—stomach cancer	0.00142	0.00244	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—HRH4—stomach cancer	0.00141	0.00338	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—KISS1—stomach cancer	0.00139	0.00332	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—GAST—stomach cancer	0.00138	0.00331	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—RGS2—stomach cancer	0.00138	0.00331	CbGpPWpGaD
Betahistine—Urticaria—Capecitabine—stomach cancer	0.00137	0.00236	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—stomach cancer	0.00137	0.00235	CcSEcCtD
Betahistine—Convulsion—Methotrexate—stomach cancer	0.00137	0.00235	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—stomach cancer	0.00135	0.00231	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00133	0.00229	CcSEcCtD
Betahistine—Malaise—Epirubicin—stomach cancer	0.00133	0.00229	CcSEcCtD
Betahistine—Discomfort—Methotrexate—stomach cancer	0.00133	0.00228	CcSEcCtD
Betahistine—Hypersensitivity—Docetaxel—stomach cancer	0.00132	0.00226	CcSEcCtD
Betahistine—Confusional state—Methotrexate—stomach cancer	0.0013	0.00223	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—stomach cancer	0.00129	0.00221	CcSEcCtD
Betahistine—Asthenia—Docetaxel—stomach cancer	0.00128	0.0022	CcSEcCtD
Betahistine—Convulsion—Epirubicin—stomach cancer	0.00128	0.0022	CcSEcCtD
Betahistine—Hypersensitivity—Capecitabine—stomach cancer	0.00127	0.00219	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—stomach cancer	0.00127	0.00218	CcSEcCtD
Betahistine—Pruritus—Docetaxel—stomach cancer	0.00126	0.00217	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—stomach cancer	0.00126	0.00217	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—KISS1—stomach cancer	0.00126	0.00301	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—KISS1R—stomach cancer	0.00126	0.00301	CbGpPWpGaD
Betahistine—Skin disorder—Methotrexate—stomach cancer	0.00125	0.00215	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00125	0.00214	CcSEcCtD
Betahistine—Discomfort—Epirubicin—stomach cancer	0.00124	0.00213	CcSEcCtD
Betahistine—Asthenia—Capecitabine—stomach cancer	0.00124	0.00213	CcSEcCtD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—stomach cancer	0.00124	0.00296	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—stomach cancer	0.00124	0.00296	CbGpPWpGaD
Betahistine—Malaise—Doxorubicin—stomach cancer	0.00123	0.00212	CcSEcCtD
Betahistine—Pruritus—Capecitabine—stomach cancer	0.00122	0.0021	CcSEcCtD
Betahistine—Diarrhoea—Docetaxel—stomach cancer	0.00122	0.0021	CcSEcCtD
Betahistine—Confusional state—Epirubicin—stomach cancer	0.00121	0.00209	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—stomach cancer	0.0012	0.00207	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.00119	0.00286	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—RGS2—stomach cancer	0.00119	0.00285	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—GAST—stomach cancer	0.00119	0.00285	CbGpPWpGaD
Betahistine—Convulsion—Doxorubicin—stomach cancer	0.00118	0.00203	CcSEcCtD
Betahistine—Diarrhoea—Capecitabine—stomach cancer	0.00118	0.00203	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—stomach cancer	0.00118	0.00203	CcSEcCtD
Betahistine—Dizziness—Docetaxel—stomach cancer	0.00118	0.00203	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—stomach cancer	0.00118	0.00202	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—stomach cancer	0.00117	0.00201	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—ADRB2—stomach cancer	0.00117	0.00279	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GLI3—stomach cancer	0.00115	0.00276	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KISS1R—stomach cancer	0.00115	0.00276	CbGpPWpGaD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00115	0.00198	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—stomach cancer	0.00115	0.00197	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—stomach cancer	0.00115	0.00197	CcSEcCtD
Betahistine—Somnolence—Methotrexate—stomach cancer	0.00114	0.00197	CcSEcCtD
Betahistine—Dizziness—Capecitabine—stomach cancer	0.00114	0.00197	CcSEcCtD
Betahistine—Vomiting—Docetaxel—stomach cancer	0.00114	0.00195	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—stomach cancer	0.00113	0.00195	CcSEcCtD
Betahistine—Rash—Docetaxel—stomach cancer	0.00113	0.00194	CcSEcCtD
Betahistine—Dermatitis—Docetaxel—stomach cancer	0.00112	0.00193	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—stomach cancer	0.00112	0.00193	CcSEcCtD
Betahistine—Headache—Docetaxel—stomach cancer	0.00112	0.00192	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—stomach cancer	0.00111	0.00192	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00111	0.00191	CcSEcCtD
Betahistine—Fatigue—Methotrexate—stomach cancer	0.00111	0.00191	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—RBP1—stomach cancer	0.0011	0.00263	CbGpPWpGaD
Betahistine—Vomiting—Capecitabine—stomach cancer	0.0011	0.00189	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—stomach cancer	0.00109	0.00188	CcSEcCtD
Betahistine—Rash—Capecitabine—stomach cancer	0.00109	0.00187	CcSEcCtD
Betahistine—Dermatitis—Capecitabine—stomach cancer	0.00109	0.00187	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—stomach cancer	0.00109	0.00187	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—GAST—stomach cancer	0.00108	0.00259	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—RGS2—stomach cancer	0.00108	0.00259	CbGpPWpGaD
Betahistine—Headache—Capecitabine—stomach cancer	0.00108	0.00186	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—stomach cancer	0.00108	0.00186	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—stomach cancer	0.00107	0.00185	CcSEcCtD
Betahistine—Somnolence—Epirubicin—stomach cancer	0.00107	0.00184	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.00106	0.00255	CbGpPWpGaD
Betahistine—Nausea—Docetaxel—stomach cancer	0.00106	0.00182	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—stomach cancer	0.00106	0.00182	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—stomach cancer	0.00106	0.00182	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00104	0.00179	CcSEcCtD
Betahistine—Fatigue—Epirubicin—stomach cancer	0.00104	0.00178	CcSEcCtD
Betahistine—HRH1—G alpha (q) signalling events—F2R—stomach cancer	0.00104	0.00248	CbGpPWpGaD
Betahistine—Nausea—Capecitabine—stomach cancer	0.00103	0.00177	CcSEcCtD
Betahistine—Urticaria—Methotrexate—stomach cancer	0.00102	0.00176	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—stomach cancer	0.000994	0.00171	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—stomach cancer	0.000993	0.00171	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—stomach cancer	0.000991	0.0017	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—stomach cancer	0.000981	0.00169	CcSEcCtD
Betahistine—HRH1—G alpha (q) signalling events—ANXA1—stomach cancer	0.000974	0.00233	CbGpPWpGaD
Betahistine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000962	0.00165	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—stomach cancer	0.000961	0.00165	CcSEcCtD
Betahistine—Urticaria—Epirubicin—stomach cancer	0.000957	0.00164	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—stomach cancer	0.000948	0.00163	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—CXCL8—stomach cancer	0.000931	0.00223	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—stomach cancer	0.000927	0.00222	CbGpPWpGaD
Betahistine—Asthenia—Methotrexate—stomach cancer	0.000923	0.00159	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—stomach cancer	0.000918	0.00158	CcSEcCtD
Betahistine—Pruritus—Methotrexate—stomach cancer	0.000911	0.00157	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—HRH4—stomach cancer	0.00091	0.00218	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGTR2—stomach cancer	0.000904	0.00216	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—WWOX—stomach cancer	0.000898	0.00215	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—F2R—stomach cancer	0.000894	0.00214	CbGpPWpGaD
Betahistine—Hypersensitivity—Epirubicin—stomach cancer	0.000887	0.00153	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—stomach cancer	0.000885	0.00152	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—stomach cancer	0.000881	0.00151	CcSEcCtD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—stomach cancer	0.000871	0.00208	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—HTR1A—stomach cancer	0.00087	0.00208	CbGpPWpGaD
Betahistine—Asthenia—Epirubicin—stomach cancer	0.000864	0.00149	CcSEcCtD
Betahistine—Pruritus—Epirubicin—stomach cancer	0.000852	0.00146	CcSEcCtD
Betahistine—Dizziness—Methotrexate—stomach cancer	0.000851	0.00146	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—ANXA1—stomach cancer	0.000841	0.00201	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HRH4—stomach cancer	0.000835	0.002	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—WIF1—stomach cancer	0.000835	0.002	CbGpPWpGaD
Betahistine—Diarrhoea—Epirubicin—stomach cancer	0.000824	0.00142	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—stomach cancer	0.000821	0.00141	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—AGTR2—stomach cancer	0.000821	0.00196	CbGpPWpGaD
Betahistine—Vomiting—Methotrexate—stomach cancer	0.000818	0.00141	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—ADRB1—stomach cancer	0.000814	0.00195	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—F2R—stomach cancer	0.000812	0.00194	CbGpPWpGaD
Betahistine—Rash—Methotrexate—stomach cancer	0.000812	0.00139	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—KISS1—stomach cancer	0.000811	0.00194	CbGpPWpGaD
Betahistine—Dermatitis—Methotrexate—stomach cancer	0.000811	0.00139	CcSEcCtD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00081	0.00194	CbGpPWpGaD
Betahistine—Headache—Methotrexate—stomach cancer	0.000806	0.00139	CcSEcCtD
Betahistine—HRH1—IL-4 Signaling Pathway—STAT3—stomach cancer	0.000802	0.00192	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.000801	0.00192	CbGpPWpGaD
Betahistine—Asthenia—Doxorubicin—stomach cancer	0.0008	0.00137	CcSEcCtD
Betahistine—Dizziness—Epirubicin—stomach cancer	0.000797	0.00137	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—HTR1A—stomach cancer	0.00079	0.00189	CbGpPWpGaD
Betahistine—Pruritus—Doxorubicin—stomach cancer	0.000789	0.00136	CcSEcCtD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.00078	0.00186	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKAB1—stomach cancer	0.000771	0.00184	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—MAPK3—stomach cancer	0.000766	0.00183	CbGpPWpGaD
Betahistine—Vomiting—Epirubicin—stomach cancer	0.000766	0.00132	CcSEcCtD
Betahistine—Nausea—Methotrexate—stomach cancer	0.000765	0.00131	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—ANXA1—stomach cancer	0.000763	0.00183	CbGpPWpGaD
Betahistine—Diarrhoea—Doxorubicin—stomach cancer	0.000763	0.00131	CcSEcCtD
Betahistine—Rash—Epirubicin—stomach cancer	0.000759	0.00131	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—stomach cancer	0.000759	0.0013	CcSEcCtD
Betahistine—Headache—Epirubicin—stomach cancer	0.000755	0.0013	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—KISS1—stomach cancer	0.000744	0.00178	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RNF43—stomach cancer	0.000744	0.00178	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—stomach cancer	0.000741	0.00177	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.00074	0.00177	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRB1—stomach cancer	0.000739	0.00177	CbGpPWpGaD
Betahistine—Dizziness—Doxorubicin—stomach cancer	0.000737	0.00127	CcSEcCtD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.000729	0.00174	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—MAPK1—stomach cancer	0.000729	0.00174	CbGpPWpGaD
Betahistine—Nausea—Epirubicin—stomach cancer	0.000715	0.00123	CcSEcCtD
Betahistine—HRH1—GPCR downstream signaling—KISS1R—stomach cancer	0.000711	0.0017	CbGpPWpGaD
Betahistine—Vomiting—Doxorubicin—stomach cancer	0.000709	0.00122	CcSEcCtD
Betahistine—Rash—Doxorubicin—stomach cancer	0.000703	0.00121	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—stomach cancer	0.000702	0.00121	CcSEcCtD
Betahistine—Headache—Doxorubicin—stomach cancer	0.000698	0.0012	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.000694	0.00166	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.000686	0.00164	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.000668	0.0016	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FST—stomach cancer	0.000663	0.00159	CbGpPWpGaD
Betahistine—Nausea—Doxorubicin—stomach cancer	0.000662	0.00114	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—ADRB2—stomach cancer	0.00066	0.00158	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—HBEGF—stomach cancer	0.000649	0.00155	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KISS1R—stomach cancer	0.000646	0.00154	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000645	0.00154	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GAST—stomach cancer	0.00064	0.00153	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RGS2—stomach cancer	0.00064	0.00153	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—PIK3CA—stomach cancer	0.000633	0.00151	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000625	0.00149	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGG—stomach cancer	0.000607	0.00145	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRB2—stomach cancer	0.000599	0.00143	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000591	0.00141	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PPP2R1A—stomach cancer	0.000587	0.0014	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKAA1—stomach cancer	0.000584	0.0014	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RBP4—stomach cancer	0.000564	0.00135	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCL8—stomach cancer	0.000564	0.00135	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGTR2—stomach cancer	0.000529	0.00126	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—F2R—stomach cancer	0.000523	0.00125	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—HRH4—stomach cancer	0.000514	0.00123	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—HTR1A—stomach cancer	0.000509	0.00122	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000506	0.00121	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ANXA1—stomach cancer	0.000491	0.00117	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HSPB1—stomach cancer	0.000485	0.00116	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGTR2—stomach cancer	0.000485	0.00116	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—BMP2—stomach cancer	0.00048	0.00115	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—F2R—stomach cancer	0.00048	0.00115	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRB1—stomach cancer	0.000476	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKR1C3—stomach cancer	0.000472	0.00113	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HRH4—stomach cancer	0.000467	0.00112	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HTR1A—stomach cancer	0.000467	0.00112	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000467	0.00112	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—KISS1—stomach cancer	0.000458	0.0011	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PRKCB—stomach cancer	0.000452	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ANXA1—stomach cancer	0.000451	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRB1—stomach cancer	0.000437	0.00104	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RPS6—stomach cancer	0.000417	0.000998	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000416	0.000996	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KISS1—stomach cancer	0.000416	0.000995	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PRKCB—stomach cancer	0.000411	0.000982	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6ST—stomach cancer	0.000409	0.000978	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RGS2—stomach cancer	0.000394	0.000942	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GAST—stomach cancer	0.000394	0.000942	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRB2—stomach cancer	0.000386	0.000922	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HBEGF—stomach cancer	0.000383	0.000917	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GLI3—stomach cancer	0.000382	0.000912	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KISS1R—stomach cancer	0.000382	0.000912	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6R—stomach cancer	0.000365	0.000872	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RBP1—stomach cancer	0.000364	0.00087	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—RHOA—stomach cancer	0.000363	0.000868	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RGS2—stomach cancer	0.000358	0.000856	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GAST—stomach cancer	0.000358	0.000856	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRB2—stomach cancer	0.000354	0.000846	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PPP2R1A—stomach cancer	0.000347	0.000829	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—RHOA—stomach cancer	0.00033	0.000788	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SMAD4—stomach cancer	0.000322	0.00077	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL8—stomach cancer	0.000319	0.000762	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FYN—stomach cancer	0.000306	0.000731	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGTR2—stomach cancer	0.000299	0.000714	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—WWOX—stomach cancer	0.000297	0.00071	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—F2R—stomach cancer	0.000295	0.000706	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL8—stomach cancer	0.000289	0.000692	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—HTR1A—stomach cancer	0.000287	0.000688	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGFR2—stomach cancer	0.000287	0.000686	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ANXA1—stomach cancer	0.000278	0.000664	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HRH4—stomach cancer	0.000276	0.00066	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—WIF1—stomach cancer	0.000276	0.00066	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR2—stomach cancer	0.000271	0.000649	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB1—stomach cancer	0.000269	0.000643	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—F2R—stomach cancer	0.000268	0.000641	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IRS2—stomach cancer	0.000263	0.000628	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HTR1A—stomach cancer	0.000261	0.000624	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CAV1—stomach cancer	0.000255	0.000609	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKAB1—stomach cancer	0.000255	0.000609	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOA1—stomach cancer	0.000254	0.000608	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000254	0.000607	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ANXA1—stomach cancer	0.000252	0.000603	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KISS1—stomach cancer	0.000246	0.000588	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RNF43—stomach cancer	0.000246	0.000588	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000245	0.000585	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB1—stomach cancer	0.000244	0.000584	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKCB—stomach cancer	0.000242	0.00058	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6ST—stomach cancer	0.000242	0.000578	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000241	0.000577	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000241	0.000577	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000234	0.00056	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APC—stomach cancer	0.000232	0.000555	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000228	0.000545	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK3—stomach cancer	0.000222	0.000531	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FST—stomach cancer	0.000219	0.000524	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB2—stomach cancer	0.000218	0.000521	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6R—stomach cancer	0.000215	0.000515	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HBEGF—stomach cancer	0.000214	0.000513	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK1—stomach cancer	0.000211	0.000506	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EGFR—stomach cancer	0.000211	0.000506	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GAST—stomach cancer	0.000211	0.000506	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RGS2—stomach cancer	0.000211	0.000506	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000209	0.000501	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CA—stomach cancer	0.000202	0.000483	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SERPINE1—stomach cancer	0.000202	0.000483	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGG—stomach cancer	0.0002	0.000479	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—KRAS—stomach cancer	0.0002	0.000478	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB2—stomach cancer	0.000198	0.000473	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RHOA—stomach cancer	0.000195	0.000465	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000194	0.000464	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000194	0.000463	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKAA1—stomach cancer	0.000193	0.000461	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOS3—stomach cancer	0.000193	0.000461	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RBP4—stomach cancer	0.000186	0.000446	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL8—stomach cancer	0.000186	0.000445	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000185	0.000444	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CA—stomach cancer	0.000184	0.000439	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ERBB2—stomach cancer	0.00018	0.000431	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL8—stomach cancer	0.000171	0.000409	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—HRAS—stomach cancer	0.00017	0.000406	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1B—stomach cancer	0.000167	0.000399	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—stomach cancer	0.000162	0.000389	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HSPB1—stomach cancer	0.00016	0.000383	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR2—stomach cancer	0.00016	0.000383	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCND1—stomach cancer	0.000159	0.000381	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—JUN—stomach cancer	0.000159	0.00038	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—F2R—stomach cancer	0.000158	0.000379	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BMP2—stomach cancer	0.000158	0.000379	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKR1C3—stomach cancer	0.000156	0.000373	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—stomach cancer	0.000155	0.00037	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HTR1A—stomach cancer	0.000154	0.000369	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1A—stomach cancer	0.000154	0.000368	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK8—stomach cancer	0.00015	0.000359	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PRKCB—stomach cancer	0.000149	0.000357	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ANXA1—stomach cancer	0.000149	0.000356	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB1—stomach cancer	0.000144	0.000345	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—stomach cancer	0.000139	0.000332	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RPS6—stomach cancer	0.000138	0.00033	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—stomach cancer	0.000137	0.000329	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRKCB—stomach cancer	0.000136	0.000324	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6ST—stomach cancer	0.000135	0.000323	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK3—stomach cancer	0.000131	0.000314	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MYC—stomach cancer	0.000128	0.000305	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HBEGF—stomach cancer	0.000127	0.000303	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK1—stomach cancer	0.000125	0.000299	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGFR—stomach cancer	0.000125	0.000299	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6R—stomach cancer	0.000121	0.000288	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RHOA—stomach cancer	0.00012	0.000287	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KRAS—stomach cancer	0.000118	0.000282	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB2—stomach cancer	0.000117	0.00028	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	0.000115	0.000274	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RHOA—stomach cancer	0.000109	0.00026	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CA—stomach cancer	0.000108	0.000259	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SMAD4—stomach cancer	0.000106	0.000254	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	0.000105	0.000252	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TP53—stomach cancer	0.000105	0.000251	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FYN—stomach cancer	0.000101	0.000241	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HRAS—stomach cancer	0.0001	0.00024	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—stomach cancer	9.6e-05	0.00023	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	9.56e-05	0.000229	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGFR2—stomach cancer	9.48e-05	0.000227	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IRS2—stomach cancer	8.68e-05	0.000208	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CAV1—stomach cancer	8.42e-05	0.000201	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOA1—stomach cancer	8.4e-05	0.000201	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCB—stomach cancer	8.01e-05	0.000192	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6ST—stomach cancer	7.98e-05	0.000191	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APC—stomach cancer	7.67e-05	0.000183	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	7.34e-05	0.000176	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6R—stomach cancer	7.12e-05	0.00017	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	6.99e-05	0.000167	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EGFR—stomach cancer	6.98e-05	0.000167	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	6.68e-05	0.00016	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	6.67e-05	0.000159	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KRAS—stomach cancer	6.6e-05	0.000158	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RHOA—stomach cancer	6.43e-05	0.000154	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOS3—stomach cancer	6.36e-05	0.000152	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	6.06e-05	0.000145	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB2—stomach cancer	5.95e-05	0.000142	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL8—stomach cancer	5.65e-05	0.000135	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HRAS—stomach cancer	5.61e-05	0.000134	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	5.51e-05	0.000132	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—stomach cancer	5.37e-05	0.000128	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCND1—stomach cancer	5.26e-05	0.000126	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JUN—stomach cancer	5.25e-05	0.000125	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—stomach cancer	5.11e-05	0.000122	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	5.09e-05	0.000122	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK8—stomach cancer	4.97e-05	0.000119	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—stomach cancer	4.58e-05	0.00011	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—stomach cancer	4.54e-05	0.000109	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK3—stomach cancer	4.34e-05	0.000104	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MYC—stomach cancer	4.22e-05	0.000101	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK1—stomach cancer	4.13e-05	9.87e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGFR—stomach cancer	4.13e-05	9.87e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KRAS—stomach cancer	3.9e-05	9.32e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	3.58e-05	8.56e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TP53—stomach cancer	3.46e-05	8.28e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HRAS—stomach cancer	3.31e-05	7.92e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—stomach cancer	3.17e-05	7.58e-05	CbGpPWpGaD
